We are live on ! Find out more
RXDX

Prometheus Biosciences, Inc. Common Stock
RXDX

Delisted

RXDX was delisted on the 15th of June, 2023.

Back to rankings

49 hedge funds and large institutions have $585M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 14

38% more capital invested

Capital invested by funds: $426M → $585M (+$160M)

20% more funds holding

Funds holding: 41 → 49 (+8)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

Holders
49
Holders Change
+8
Holders Change %
+19.51%
% of All Funds
0.85%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
9
Reduced
10
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$13.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$9.35M
3
PIM
Platinum Investment Management
Australia
+$4.77M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.3M
5
State Street
State Street
Massachusetts
+$3.48M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.59M
2
CAM
Cormorant Asset Management
Massachusetts
-$5.58M
3
GPP
Great Point Partners
Connecticut
-$4.57M
4
Millennium Management
Millennium Management
New York
-$3.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Laurion Capital Management
New York
$1.52M +$270K +12,084 +24%
Citadel Advisors
27
Citadel Advisors
Florida
$944K -$395K -17,700 -32%
N
28
Nuveen
North Carolina
$795K +$722K +32,373 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$771K +$701K +31,404 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$383K +$348K +15,614 New
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$361K +$328K +14,700 New
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$255K +$231K +10,369 New
JF
33
Jump Financial
Illinois
$253K +$230K +10,311 New
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$238K +$216K +9,700 New
VEA
35
Virtus ETF Advisers
New York
$234K +$212K +9,519 New
KCM
36
Kingdon Capital Management
New York
$204K -$707K -31,683 -79%
JP Morgan Chase
37
JP Morgan Chase
New York
$168K +$152K +6,822 New
Deutsche Bank
38
Deutsche Bank
Germany
$165K +$150K +6,709 New
Bank of America
39
Bank of America
North Carolina
$102K +$65K +2,913 +237%
Morgan Stanley
40
Morgan Stanley
New York
$71K +$57.3K +2,567 +888%
SO
41
STRS Ohio
Ohio
$63K +$58K +2,600 New
TRCT
42
Tower Research Capital (TRC)
New York
$25K +$22.3K +999 New
AIP
43
Ameritas Investment Partners
Nebraska
$22K +$19.8K +886 New
Legal & General Group
44
Legal & General Group
United Kingdom
$22K +$20.1K +902 New
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$19K +$17.2K +773 New
Citigroup
46
Citigroup
New York
$13K +$12K +537 New
PAM
47
Panagora Asset Management
Massachusetts
$6K +$5.46K +245 New
Wells Fargo
48
Wells Fargo
California
$2K +$1.63K +73 New
AIG
49
American International Group
New York
$156 +$141K +6,333 New
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
– -$9.59M -525,000 Closed
1
2
3

RXDX Hedge Fund Activity: Q2 2021 in Review

49 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Prometheus Biosciences, Inc. Common Stock (RXDX) for Q2 2021, worth a combined $585M — up 38% from $426M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new RXDX positions and 14 closed out — a net gain of 8 holders — while 9 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $13.2M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $9.59M sold.

  • 49 institutional investors held Prometheus Biosciences, Inc. Common Stock (RXDX) as of Q2 2021, up from 41 in Q1 2021.
  • Funds reported $585M of Prometheus Biosciences, Inc. Common Stock stock for Q2 2021, up 38% quarter-over-quarter.
  • 22 funds opened new Prometheus Biosciences, Inc. Common Stock positions in Q2 2021 and 14 closed out, a net change of +8 holders.
  • The largest Prometheus Biosciences, Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $13.2M added.
  • The largest Prometheus Biosciences, Inc. Common Stock seller in Q2 2021 was T. Rowe Price Associates, an estimated $9.59M sold.

Based on aggregated 13F filings for Q2 2021.